Rafarma Pharmaceuticals, Inc. (RAFA)
OTCMKTS · Delayed Price · Currency is USD
0.0148
-0.0077 (-34.22%)
At close: Nov 6, 2026
Rafarma Pharmaceuticals Company Description
Rafarma Pharmaceuticals, Inc. engages in the development and production of medical equipment.
It is also involved in the supply of equipment for hospitals and clinics. Rafarma Pharmaceuticals, Inc. was formerly known as Johnston Acquisition Corp. and changed its name to Rafarma Pharmaceuticals, Inc. in October 2012.
The company was incorporated in 1982 and is based in Draper, Utah. As of October 19, 2020, Rafarma Pharmaceuticals, Inc. operates as a subsidiary of R.
& D. Biocogency Laboratories Inc. Ltd.
Rafarma Pharmaceuticals, Inc.

| Country | United States |
| Founded | 1982 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
Contact Details
Address: 12465 South Fort St Draper, Utah 84020 United States | |
| Phone | 307 429 2029 |
| Website | rafarma.co |
Stock Details
| Ticker Symbol | RAFA |
| Exchange | OTCMKTS |
| Stock Type | Common Stock |
| Fiscal Year | April - March |
| Reporting Currency | USD |
| ISIN Number | US75062C1009 |
| SIC Code | 6799 |
Key Executives
| Name | Position |
|---|---|
| Sergey Brusnitsin J.D., Ph.D. | Chief Financial Officer and Director |
| Anucha Phetpheng | Executive Vice-President for Thai Operations |
| Alexander Ageev Esq. | Secretary, Treasurer and Director |